🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Ovarian cancer-derived IL-4 promotes immunotherapy resistance: Cell cell.com/cell/fulltext/… Icahn Genomics Institute Icahn School of Medicine at Mount Sinai Brown Lab, Baccarini lab Miriam Merad, MD, PhD Peter Sorger @SantagataLab Dmitriy Zamarin MD PhD Chiara Falcomatà Jia-Ren Lin Nelson LaMarche .

Very excited to be presenting work from Miriam Merad, MD, PhD lab Icahn School of Medicine at Mount Sinai Lipschultz Precision Immunology Institute on mechanisms of pathogenic myelopoiesis in cancer and aging Society for Immunotherapy of Cancer and to be receiving a Young Investigator Award #SITC2024 ! Join us tomorrow in Session 208a 5:15 pm CST.

IL-1 signaling in aging and cancer: An inflammaging feedback loop unveiled dlvr.it/TGC7LZ

We're THRILLED to congratulate Matthew D. Park, Ph.D. on being named one of Forbes 30 under 30 in Healthcare 🥳!!! Check out his recent paper in Science Magazine on aging and cancer below, and his Forbes Under 30 profile >>> forbes.com/profile/matthe… science.org/doi/10.1126/sc…

.Matthew D. Park, Ph.D. on the 2025 30 Under 30 - Healthcare - Park's doctoral research, published in Science, has advanced our understanding of cancer as an aging-related forbes.com/profile/matthe… meradlab.org/matthew-park Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai

I'm very excited to share that I have been named one of Forbes Forbes Under 30 in Healthcare for my work on cancer and aging. It's an overwhelming honor to be recognized this way, thanks to the support of Miriam Merad, MD, PhD Lipschultz Precision Immunology Institute Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute #ForbesUnder30

Congratulations to Matthew D. Park, Ph.D., MD/PhD Candidate, on being recognized in Forbes Under 30 Healthcare list! Forbes #ForbesUnder30

Matthew Park, PhD is a sixth-year candidate in the MD-PhD program at Icahn School of Medicine at Mount Sinai. He was recognized in the 2025 Forbes Under 30 Healthcare list. Read how his research has advanced the understanding of cancer as an aging-related disease: mshs.co/4gEPgSn #ForbesUnder30

Cholesterol mobilization regulates DC maturation and the immunogenic response to cancer nature.com/articles/s4159… Nature Immunology Miriam Merad, MD, PhD Meriem Belabed Matthew D. Park, Ph.D.

I'm excited to share a new review Nature Reviews Cancer from Miriam Merad, MD, PhD lab Lipschultz Precision Immunology Institute led by X-less Chang Moon. We offer one of the most comprehensive reviews of DC functions, phenotypes, and maturation at steady-state and in cancer. It is a must-read! doi.org/10.1038/s41568…

I recently had the opp. to appear as a guest on the Good Life Project hosted by Jonathan Fields (he/him) to discuss my work on cancer and aging and the amazing clinical trial work happening Lipschultz Precision Immunology Institute Icahn School of Medicine at Mount Sinai Grad School at Icahn Mount Sinai goodlifeproject.com/podcast/aging-… feeds.acast.com/public/shows/6…

A must-read review on the recent developments in the field that refine our understanding of IL-1 in cancer development and progression: Distinguishing pathogenic inflammation from other signals and knowing when and where it drives disease are essential!

I'm very excited to be participating in the American Junior Investigator's Association (AJIA) regional meeting at Icahn School of Medicine at Mount Sinai as a short talk speaker! Looking forward to connecting w members of the organization and sharing the exciting work done and ongoing at Miriam Merad, MD, PhD lab The Tisch Cancer Institute Lipschultz Precision Immunology Institute!

Congratulations to the APSA advocacy team on this new piece highlighting mental health challenges and solutions in medical scientist trainee populations. SinaiMSTP nature.com/articles/s4385…